This webinar explores the innovative biomarkers available for clinical research in Parkinson’s Disease. Sponsors developing novel therapies in this indication face significant hurdles including the need to identify objective markers of clinical effect in trial participants. Various EEG approaches are available to researchers, watch the replay to discover how Biotrial exposes their added value.